mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant
2022 · Cell Reports Medicine · 215 citations
https://doi.org/10.1016/j.xcrm.2022.100529
H
Hady Samaha
Emory University(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
34
Papers
1.1K
Citations
14
h-index
17
i10-index
Hady Samaha is an academic researcher from Emory University. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & COVID-19 Clinical Research Studies & Long-Term Effects of COVID-19. The author has an h-index of 14, co-authored 29 publications.
ORCID: 0000-0002-9124-7820Papers by this author
worksComparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial
2023 · Nature Medicine · 53 citations
https://doi.org/10.1038/s41591-023-02503-4
Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patients
2023 · Cell Reports Medicine · 49 citations
https://doi.org/10.1016/j.xcrm.2023.101079
IgM N-glycosylation correlates with COVID-19 severity and rate of complement deposition
2024 · Nature Communications · 23 citations
https://doi.org/10.1038/s41467-023-44211-0
Efficacy and Durability of Immune Response after Receipt of HPV Vaccines in People Living with HIV
2023 · Vaccines · 12 citations
https://doi.org/10.3390/vaccines11061067
Host-microbe multiomic profiling identifies distinct COVID-19 immune dysregulation in solid organ transplant recipients
2025 · Nature Communications · 5 citations
https://doi.org/10.1038/s41467-025-55823-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat